Eden Research (LON:EDEN) Stock Price Down 13.2% – Time to Sell?

Eden Research plc (LON:EDEN)’s stock price dropped 13.2% during mid-day trading on Monday . The stock traded as low as GBX 2.26 ($0.03) and last traded at GBX 2.37 ($0.03). Approximately 1,775,147 shares changed hands during mid-day trading, an increase of 133% from the average daily volume of 762,776 shares. The stock had previously closed at GBX 2.73 ($0.04).

Eden Research Price Performance

The stock has a fifty day moving average of GBX 3.36 and a 200 day moving average of GBX 3.71. The company has a debt-to-equity ratio of 1.26, a current ratio of 3.80 and a quick ratio of 2.42. The stock has a market cap of £14.35 million, a price-to-earnings ratio of -9.42 and a beta of 0.92.

Insider Transactions at Eden Research

In other Eden Research news, insider Sean M. Smith bought 426,986 shares of the company’s stock in a transaction dated Tuesday, April 1st. The shares were purchased at an average cost of GBX 234 ($3.04) per share, for a total transaction of £999,147.24 ($1,297,425.32). Also, insider Alexander John Abrey purchased 540,540 shares of the business’s stock in a transaction that occurred on Tuesday, January 28th. The stock was acquired at an average price of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($28,076.35). Insiders have acquired 1,391,473 shares of company stock worth $103,604,725 over the last 90 days. 14.02% of the stock is currently owned by company insiders.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.